Ogawa E.Toyoda H.Iio E.Jun D.W.Huang C.-F.Enomoto M.Hsu Y.-C.Haga H.Iwane S.Wong G.Lee D.H.Tada T.CHEN-HUA LIUChuang W.-L.Hayashi J.Cheung R.Yasuda S.Tseng C.-H.Takahashi H.Tran S.Yeo Y.H.Henry L.Barnett S.D.Nomura H.Nakamuta M.Dai C.-Y.Huang J.-F.Yang H.-I.Lee M.-H.Jun M.J.JIA-HORNG KAOEguchi Y.Ueno Y.Tamori A.Furusyo N.Yu M.-L.Tanaka Y.Nguyen M.H.Ahn S.B.Azuma K.Dohmen K.Jeong J.Y.Jung J.H.Kajiwara E.Kato M.Kawano A.Koyanagi T.Ooho A.Park S.H.Satoh T.Shimoda S.Song D.S.Takahashi K.Yeh M.-L.Yoon E.L.Real-World Evidence from the Asia Liver Consortium Investigators2021-09-042021-09-0420201058-4838https://www.scopus.com/inward/record.uri?eid=2-s2.0-85099326545&doi=10.1093%2fcid%2fciz1160&partnerID=40&md5=0acf1d558af90ce0382ed5fb68e36925https://scholars.lib.ntu.edu.tw/handle/123456789/581722[SDGs]SDG3Hepatitis C virus cure rates are reduced in patients with active but not inactive hepatocellular carcinoma: A practice implicationjournal article10.1093/cid/ciz1160317779402-s2.0-85099326545